Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-04-28
1988-12-20
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 514311, 514312, 514277, 514344, 514345, 514398, 514399, 514406, 514407, 514419, 514424, 514427, 514432, 514461, 514473, 514510, 2604105, 260408, 544298, 544318, 544319, 546153, 546294, 546301, 548337, 548346, 548371, 548372, 548375, 548484, 548542, 548543, 548551, 548556, 549 23, 549 28, 549479, 560 8, 560 65, 560 73, 560105, 560108, 560139, A61K 3122, A61K 31275, A61K 31415, A61K 3144, C07C 6935, C07C12115
Patent
active
047925566
ABSTRACT:
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: ##STR1## wherein: R.sup.1 and R.sup.2 are the same and are lower alkoxy or optionally substituted phenoxy,
REFERENCES:
patent: 4466981 (1984-08-01), Jones et al.
Murthy D. V. K.
Venuti Michael C.
Young John M.
Lewis Brian
Moran Tom M.
Roth Carol J.
Shippen Michael L.
Syntex (U.S.A.) Inc.
LandOfFree
Naphthalene anti-psoriatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalene anti-psoriatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene anti-psoriatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1909673